{"id":"W4296087054","doi":"10.3390/curroncol29090506","title":"Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regorafenib; Pembrolizumab; Apatinib; Oncology; Immunotherapy; Chemotherapy; Bevacizumab; Internal medicine; Trastuzumab; Lapatinib; Cancer; Cabozantinib; Targeted therapy; Breast cancer; Colorectal cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00106007,0.0005915671,0.001530245,0.001036574,0.0002388312,0.001216383,0.0006406072,0.0009639141,0.004185091],"category_scores_gemma":[0.001144241,0.0001624979,0.0007893956,0.0009874216,0.0004725505,0.002039987,0.0005873375,0.002100547,0.001159028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006168298,"about_ca_system_score_gemma":0.001136409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001180429,"about_ca_topic_score_gemma":0.002282974,"domain_scores_codex":[0.9997502,0.00006776579,0.0000379479,0.00004196429,0.00007579217,0.00002634439],"domain_scores_gemma":[0.9992532,0.0004016937,0.00008978198,0.00002483071,0.0001811517,0.00004923655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009570567,0.00006757087,0.0001670691,0.01629538,0.00009415982,0.00007702549,0.00006581011,0.0002357432,0.0005937861,0.003012587,0.02277032,0.956525],"study_design_scores_gemma":[0.00003373264,0.0001698993,0.001018872,0.01149675,0.0001906066,0.000765198,0.0001415725,0.0001008089,0.00023321,0.002652752,0.9831755,0.00002102793],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009419001,0.9985207,0.00006580799,0.0007374001,0.0001796725,0.000002752251,0.00001001024,0.000004477709,0.0003849617],"genre_scores_gemma":[0.000898197,0.9978094,0.0001494906,0.0005025776,0.0002789512,0.000004584654,0.00002574373,0.000001995621,0.0003290145],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004185091,"threshold_uncertainty_score":0.01400048,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.277369699669468,"score_gpt":0.4878430629012566,"score_spread":0.2104733632317886,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}